In the midst of more economic uncertainty this year, healthcare private equity (PE) will continue to be attractive as a safe haven for investors, says Sebastien Lamy, a partner in Bain’s Healthcare and Private Equity Practice. This is a near 60% increase from the US$23.1 billion recorded in 2015. According to Bain & Company’s sixth Global Healthcare Private Equity and Corporate M&A Report released on April 20, the deal count rose to 206 last year from 199 in 2015.